InBody Co.,Ltd (KOSDAQ:041830)
25,250
-550 (-2.13%)
Jun 13, 2025, 3:30 PM KST
InBody Co.,Ltd Revenue
InBody Co.,Ltd had revenue of 55.58B KRW in the quarter ending March 31, 2025, with 14.77% growth. This brings the company's revenue in the last twelve months to 211.62B, up 20.41% year-over-year. In the year 2024, InBody Co.,Ltd had annual revenue of 204.46B with 20.03% growth.
Revenue (ttm)
211.62B
Revenue Growth
+20.41%
P/S Ratio
1.51
Revenue / Employee
678.27M
Employees
312
Market Cap
319.84B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 204.46B | 34.11B | 20.03% |
Dec 31, 2023 | 170.35B | 10.35B | 6.47% |
Dec 31, 2022 | 160.00B | 22.17B | 16.08% |
Dec 31, 2021 | 137.84B | 30.71B | 28.67% |
Dec 31, 2020 | 107.12B | -9.94B | -8.49% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
Peptron | 4.30B |